Our meeting aims to bring together leading researchers with diverse perspectives on different aspects of cancer-related inflammation and tumor-associated stress responses to share their latest findings in basic tumor biology as well as translational advances, and to synthesize knowledge to drive future research agendas. The conference will place special emphasis on interdisciplinary approaches needed for new discoveries that will form the mechanistic basis for the development of better therapeutics to target stromal pathways in primary and metastatic tumor microenvironment.
Deadline for registration
January 27, 2026
Deadline for abstract submission
January 1, 2026
